224776-54-9Relevant academic research and scientific papers
N-1 substituted pyrimidin-4-ones: Novel, orally active inhibitors of lipoprotein-associated phospholipase A2
Boyd, Helen F.,Fell, Stephen C. M.,Flynn, Sean T.,Hickey, Deirdre M. B.,Ife, Robert J.,Leach, Colin A.,Macphee, Colin H.,Milliner, Kevin J.,Moores, Kitty E.,Pinto, Ivan L.,Porter, Rod A.,Rawlings,Smith, Stephen A.,Stansfield, Ian G.,Tew, David G.,Theobald, Colin J.,Whittaker, Caroline M.
, p. 2557 - 2561 (2007/10/03)
From two related series of 2-(alkylthio)-pyrimidones, a novel series of 1-((amidolinked)-alkyl)-pyrimidones has been designed as nanomolar inhibitors of human lipoprotein-associated phopholipase A2. These compounds show greatly enhanced activity in isolated plasma. Selected derivatives such as compounds 51 and 52 are orally active with a good duration of action. (C) 2000 Elsevier Science Ltd.
